Results 21 to 30 of about 35,745 (266)

Cholera vaccine clinical trials: A cross-sectional analysis of clinical trials registries

open access: yesHuman Vaccines & Immunotherapeutics, 2023
Cholera has been one of the world’s biggest public health challenges for centuries. The presence of this disease brings into focus the social determinants of health in different parts of the world.
Lindi Mathebula   +5 more
doaj   +1 more source

Immunoinformatics-Based Multi-Epitope Vaccine Targeting Helicobacter Pylori. [PDF]

open access: yesCancer Rep (Hoboken)
ABSTRACT Background The rising global incidence of Helicobacter pylori‐related diseases, particularly gastric cancer, underscores the urgent need for effective preventive vaccines, motivating the exploration of innovative immunoinformatic strategies to address this public health challenge.
Pasha AVK   +4 more
europepmc   +2 more sources

Urban Cholera transmission hotspots and their implications for Reactive Vaccination: evidence from Bissau city, Guinea Bissau [PDF]

open access: yes, 2012
Use of cholera vaccines in response to epidemics (reactive vaccination) may provide an effective supplement to traditional control measures. In Haiti, reactive vaccination was considered but, until recently, rejected in part due to limited global supply ...
Azman, A S   +7 more
core   +8 more sources

Efficacy and Safety of Cholera Vaccines

open access: yesБиопрепараты: Профилактика, диагностика, лечение, 2018
Cholera is an acute diarrheal disease caused by toxigenic strains of Vibrio cholerae O1 and O139 serogroups. It still remains a major  global healthcare problem.
A. A. Goryaev   +3 more
doaj   +1 more source

Vaccination in emergencies. [PDF]

open access: yes, 1999
Nongovernmental organisations (NGOs) are the main actors of vaccine delivery during complex humanitarian emergencies such as large population displacements.
Paquet, C
core   +2 more sources

Advances in enteric disease vaccines: from innovation to implementation [PDF]

open access: yes, 2014
The Seventh International Conference on Vaccines for Enteric Diseases Bangkok, Thailand, 6–8 November 2013 Hosting 222 participants from more than 25 countries, the Seventh International Conference on Vaccines for Enteric Diseases (VED 2013) displayed ...
Parker, EPK
core   +1 more source

Intradermal cholera vaccination [PDF]

open access: yesJournal of Hygiene, 1964
The protection afforded by cholera vaccine administered by the intradermal route, and demonstrated by active and passive mouse protection tests, active guinea-pig protection tests, and agglutination titres, is excellent and equal to that given by subcutaneous inoculation.It is suggested that cholera vaccine administered by the intradermal route would ...
openaire   +2 more sources

Improving immunization approaches to cholera

open access: yesExpert Review of Vaccines, 2017
Introduction: Cholera’s impact is greatest in resource-limited countries. In the last decade several large epidemics have led to a global push to improve and implement the tools for cholera prevention and control.
Amit Saha   +4 more
doaj   +1 more source

Stemming cholera tides in Zimbabwe through mass vaccination

open access: yesInternational Journal of Infectious Diseases, 2020
Background: In 2018, Zimbabwe declared another major cholera outbreak a decade after recording one of the worst cholera outbreaks in Africa. Methods: A mathematical model for cholera was used to estimate the magnitude of the cholera outbreak and ...
Zindoga Mukandavire   +5 more
doaj   +1 more source

Nontoxigenic Vibrio cholerae Challenge Strains for Evaluating Vaccine Efficacy and Inferring Mechanisms of Protection

open access: yesmBio, 2022
Human challenge studies are instrumental for testing cholera vaccines, but these studies use outdated strains and require inpatient facilities. Here, we created next-generation isogenic Ogawa and Inaba O1 V.
Bolutife Fakoya   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy